Position in AKTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,070,230
New position
Shares Held
507,000
first reported quarter
Ownership
0.917%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $1,508,394,820 across 48 Biotechnology names. AKTS ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,408,871 | $130,151,502 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
2,197,385 | $108,023,446 | |
| 3 | ARGX |
Argenx SE
|
125,657 | $91,761,024 | |
| 4 | INSM |
INSMED Inc
|
546,310 | $89,332,611 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
519,558 | $87,815,693 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
1,374,292 | $79,860,108 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,312,534 | $62,962,255 | |
| 8 | BLTE |
Belite Bio, Inc
|
357,650 | $57,023,716 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,070,230 | 507,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||